Research

Hormonal

GLP-1 RAs can cause clinically significant drug-drug interactions (DDIs) by delaying gastric emptying, particularly affecting the absorption of oral contraceptives and levothyroxine.

If you take oral contraceptives or levothyroxine, be aware that GLP-1 drugs can change how well these work by slowing stomach emptying. Your doctor may need to monitor your levels or adjust doses. Use backup contraception if advised.

GoodQualifiesHIGH confidence
Mechanism-of-action-mediated DDIs are currently limited to those involving delayed gastric emptying... significant changes in exposure were observed for oral contraceptives and levothyroxine following the administration of tirzepatide and oral semaglutide, respectively, indicating the need for close monitoring in these instances.
Jee Sun Min et al. · Drug Design Development and Therapy · 2025

Why this rating

Based on specific clinical observations noted in the review, though described as 'limited' compared to enzyme-mediated DDIs.

Source

A Comprehensive Review on the Pharmacokinetics and Drug−Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist

Jee Sun Min et al. · Drug Design Development and Therapy · 2025

DOI 10.2147/dddt.s506957

narrative_reviewCited 48×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →